NCT04505761

Brief Summary

Patients who receive intensive care are known to be at high risk for physical, psychological, and cognitive impairments, a constellation known as PICS. COVID-19 patients are expected to have high chances of suffering from PICS (PICS-COV) as they frequently require several weeks of intensive care and traditional PICS preventive measures are virtually impossible due to infection control precautions, prone positioning, and deprivation of social contact. To prevent PICS after ICU discharge in COVID-19 patients, physical therapy is recommended. From recent but limited experience it appears that even patients with COVID-19 who have not been admitted to the ICU can suffer from impairments in the same domains and sometimes to a similar degree of severity. Also for these patient group rehabilitation seems warranted. Yet, the resources needed to provide rehabilitation treatment to COVID-19 patients are inadequate because healthcare systems faced a shortage of high-quality treatment for these impairments already before the COVID-19 crisis emerged. Virtual Reality (VR) provides potential to healthcare practitioners to administer fast, temporary, and tailor-made rehabilitation services at a distance, and offers a solution to address the impending surge of demand for rehabilitation after COVID-19 infection. VR consists of a head mounted display (HMD) that can bring the user by computer-generated visuals into an immersive, realistic multi-sensory environment. Current VR technology is accessible, easy in use for a large audience, and safe in use. There already exist multiple VR applications for providing physical, psychological, and cognitive rehabilitation. These applications have been brought together in a VR suite for rehabilitation after COVID-19. Patients visiting a physiotherapist for rehabilitation from COVID-19 will be asked to participate in this study. They receive a VR HMD for training purposes. This study aims to understand the usability, feasibility, and tolerability of VR for rehabilitation after COVID-19, and to pilot the effectiveness of VR improving the physical ability, mental and cognitive status of patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 3, 2020

Completed
29 days until next milestone

Study Start

First participant enrolled

August 1, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 10, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
Last Updated

April 6, 2021

Status Verified

June 1, 2020

Enrollment Period

6 months

First QC Date

July 3, 2020

Last Update Submit

April 5, 2021

Conditions

Keywords

Virtual RealityRehabilitationPost-intensive care syndrome

Outcome Measures

Primary Outcomes (3)

  • Semi-structured interview with 15 patients on their experiences of VR for rehabilitation from COVID-19.

    At the end of the study, 15 patients will be interviewed about their experiences using VR for rehabilitation from COVID-19. The interview will be semi-structured, including questions on usability, tolerability and efficacy of VR according to the patients. The interviews will be recorded, written out and coded by means of grounded theory analysis in Atlas.ti. Themes and subthemes will be constructed.

    Day 42

  • Use of VR

    By means of digital tracking in the VR goggles, we aim to understand what games are used most often by the participants.

    Day 42

  • Semi-structured interviews with physiotherapists on their experiences of VR for rehabilitation from COVID-19.

    At the end of the study, 10 physiotherapists will be interviewed about their experiences using VR for rehabilitation from COVID-19. The interview will be semi-structured, including questions on usability, tolerability and efficacy of VR according to the physiotherapists. The interviews will be recorded, written out and coded by means of grounded theory analysis in Atlas.ti. Themes and subthemes will be constructed.

    Day 42

Secondary Outcomes (10)

  • Change in baseline performance test (guidelines KNGF) - Patient specific complaints.

    Day 0, day 42

  • Change in baseline performance test (guidelines KNGF) - 6 minute walk test

    Day 0, Day 42

  • Change in baseline performance test (guidelines KNGF) - one-repetition maximum test

    Day 0, Day 42

  • Change in baseline performance test (guidelines KNGF) - 30 sec sit to stand

    Day 0, Day 42

  • Change in baseline performance test (guidelines KNGF) - Borgscale for fatigue

    Day 0, Day 42

  • +5 more secondary outcomes

Other Outcomes (1)

  • Patient characteristics related to use of VR

    Day 0

Study Arms (1)

Intervention group

EXPERIMENTAL

Participants will receive Virtual Reality as an add-on to standard physiotherapy after COVID-19.

Device: Virtual Reality

Interventions

Participants will use a Virtual Reality headset with a range of applications applicable for rehabilitation after COVID-19. Applications target physical, psychological, and cognitive rehabilitation. VR headset will be used for six weeks first at the physiotherapist's practice, and when possible, at home.

Intervention group

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patient has had COVID-19.
  • Patient has an indication for physical therapy in the context of rehabilitation after COVID-19.
  • Patient is willing and able to comply with the study protocol.
  • Patient is at least 16 years old on the day the informed consent form will be signed.
  • Patient can read and understand the Dutch language.

You may not qualify if:

  • The patient is participating in another study interfering with this study.
  • Patient has difficulties to handle virtual reality:
  • Patient suffers from delirium or acute confusional state.
  • Patient has (a history of) dementia, seizure, or epilepsy.
  • Patient has severe hearing/visual impairment not corrected.
  • The skin of the patient's head or face is not intact (for example head wounds, psoriasis, eczema).
  • Patient has a high risk of contamination with a therapy resistant micro-organism e.g. MRSA.
  • Patients suffers from severe anxiety or depression (HADS≥16).
  • Red flags (see Appendix 1).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Radboud university medical center

Nijmegen, Gelderland, 6525 GA, Netherlands

Location

Related Publications (1)

  • Groenveld T, Achttien R, Smits M, de Vries M, van Heerde R, Staal B, van Goor H; COVID Rehab Group. Feasibility of Virtual Reality Exercises at Home for Post-COVID-19 Condition: Cohort Study. JMIR Rehabil Assist Technol. 2022 Aug 15;9(3):e36836. doi: 10.2196/36836.

MeSH Terms

Conditions

Coronavirus Infectionspostintensive care syndrome

Condition Hierarchy (Ancestors)

Coronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsVirus DiseasesInfections

Study Officials

  • Harry van Goor, MD, PhD

    Radboud University Medical Center

    PRINCIPAL INVESTIGATOR
  • Bart Staal, PT, PhD

    Radboud University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Participants are asked to use Virtual Reality as an add-on to standard physiotherapy for revalidation after COVID-19.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 3, 2020

First Posted

August 10, 2020

Study Start

August 1, 2020

Primary Completion

February 1, 2021

Study Completion

March 31, 2021

Last Updated

April 6, 2021

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Only upon asking.

Locations